OSTEOPENIA/OSTEOPOROSIS FOLLOW-UP AND THE EFFICACY OF TREATMENT IN POSTMENOPAUSAL WOMEN

被引:0
|
作者
Salamat, M. R. [1 ,2 ]
Shakeri, Z. [1 ]
Siavash, M. [3 ]
Tavakoli, M. B. [1 ]
Ziaei, H. R. [2 ]
Bagheri, M. Mir [2 ]
Kompany, K. [2 ]
Vafaei, H. [2 ]
机构
[1] Isfahan Univ Med Sci, Dept Med Phys & Med Engn, Esfahan, Iran
[2] Isfahan Osteoporosis Diag Ctr, Esfahan, Iran
[3] Isfahan Univ Med Sci, Dept Endocrinol & Metab, Esfahan, Iran
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S762 / S763
页数:2
相关论文
共 50 条
  • [21] FRACT: FOLLOW-UP OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AT THE FRACTURE LIAISON SERVICE OF PM&R DEPARTMENT
    Tuzun, S.
    Akarirmak, U.
    Palamar, D.
    Kulaksiz, B.
    Keles, A.
    Okutan, D.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S362 - S362
  • [22] The efficacy and safety of ipriflavone in postmenopausal women with osteopenia or osteoporosis: A systematic review and meta-analysis
    Hu, Qinsheng
    Long, Cheng
    Wu, Diwei
    You, Xuanhe
    Ran, Liyu
    Xu, Jiazhuang
    Klineberg, Eric O.
    Huang, Shishu
    Chen, Jiali
    Ning, Ning
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [23] Efficacy and Safety of Denosumab in Postmenopausal Women with Osteopenia or Osteoporosis: A Systematic Review and a Meta-analysis
    Anastasilakis, A. D.
    Toulis, K. A.
    Goulis, D. G.
    Polyzos, S. A.
    Delaroudis, S.
    Giomisi, A.
    Terpos, E.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (10) : 721 - 729
  • [24] NUTRITIONAL SUPPORT AND PHYSICAL ACTIVITY IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA OR OSTEOPOROSIS
    Rogoveanu, O. C.
    Cioroianu, G. O.
    Geormaneanu, C.
    Sas, T.
    Gofita, C.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S169 - S170
  • [25] RISK FACTORS ASSOCIATED TO OSTEOPENIA AND OSTEOPOROSIS IN SPANISH POSTMENOPAUSAL WOMEN
    Baro, Francesc
    Rodriguez Bueno, Esteban
    Guinot, Misericordia
    Roca, Beatriz
    Ruiz, Elena
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 404 - 405
  • [26] Prevalence and Predictors of Osteoporosis and Osteopenia in Postmenopausal Women of Punjab, India
    Khinda, Rubanpal
    Valecha, Srishti
    Kumar, Nitin
    Walia, J. P. S.
    Singh, Kuldeep
    Sethi, Sudhir
    Singh, Avtar
    Singh, Monica
    Singh, Puneetpal
    Mastana, Sarabjit
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (05)
  • [27] FACTORS OF RISK ASSOCIATED TO OSTEOPENIA AND OSTEOPOROSIS IN SPANISH POSTMENOPAUSAL WOMEN
    Baro, F.
    Rodriguez, E.
    Ruiz, E.
    Guinot, M.
    Roca, B.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 74 - 74
  • [28] EFFECTS OF 2 YEARS FOLLOW-UP CYCLICAL ETIDRONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    LICATA, AA
    CHESNUT, CH
    GENANT, HK
    HARRIS, ST
    JACKSON, RD
    MILLER, PD
    ROSS, PD
    WASNICH, RD
    WATTS, NB
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S141 - S141
  • [29] Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up
    Neil Majithia
    Pamela J. Atherton
    Jacqueline M. Lafky
    Nina Wagner-Johnston
    Janet Olson
    Shaker R. Dakhil
    Edith A. Perez
    Charles L. Loprinzi
    Stephanie L. Hines
    Supportive Care in Cancer, 2016, 24 : 1219 - 1226
  • [30] Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up
    Majithia, Neil
    Atherton, Pamela J.
    Lafky, Jacqueline M.
    Wagner-Johnston, Nina
    Olson, Janet
    Dakhil, Shaker R.
    Perez, Edith A.
    Loprinzi, Charles L.
    Hines, Stephanie L.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (03) : 1219 - 1226